T cell response in acute motor axonal neuropathy

International Journal of Immunopathology and Pharmacology

Volumn 22, Issue 4, 2009, Pages 1043-1050

  Cencioni, M T ^a   Notturno, F ^b   Caporale, C M ^b   Creati, B ^c   Prencipe, V ^b   Battistini, L ^a   Uncini, Antonino ^b  

^a IRCCS FONDAZIONE SANTA LUCIA   (Italy)

^b UNIVERSITY OF CHIETI   (Italy)

^c Experimental Zooprophylactic Institute G Caporale   (Italy)

Author keywords

Acute motor axonal neuropathy; Anti ganglioside antibodies; CD1; T cell response

Indexed keywords

CD1C ANTIGEN; CD27 ANTIGEN; CD8 ANTIGEN; GAMMA INTERFERON; GANGLIOSIDE GM1; LIPOPOLYSACCHARIDE; TUMOR NECROSIS FACTOR ALPHA;

ACUTE DISEASE; ADULT; AGED; ANTIBODY PRODUCTION; ARTICLE; BACTERIAL STRAIN; CAMPYLOBACTER JEJUNI; CELL ISOLATION; CELLULAR IMMUNITY; CLINICAL ARTICLE; CONTROL GROUP; CONTROLLED STUDY; CYTOKINE RELEASE; DENDRITIC CELL; FEMALE; HUMAN; HUMAN CELL; LYMPHOCYTE CULTURE; MALE; MOLECULE; MONOCYTE; MOTOR NEUROPATHY; PATHOGENESIS; PRIORITY JOURNAL; T LYMPHOCYTE;

EID: 76349117681     PISSN: 03946320     EISSN: None     Source Type: Journal    
DOI: 10.1177/039463200902200420     Document Type: Article

References (37)

1. Hughes RA, Cornblath DR. Guillain-Barré syndrome. Lancet 2005; 366:1653-66.
2. Yuki N, Noshino H, Sato S, Miyatake T. Acute axonal polyneuropathy associated with anti-GM1 antibodies following Campylobacter enteritis. Neurology 1990; 40:1900-02.
3. McKhann GM, Cornblath DR, Ho T, et al. Clinical and electrophysiological aspects of acute paralytic disease of children and young adults in northern China. Lancet 1991; 338:593-7.
4. Griffin JW, Li CY, Ho TW, et al. Guillain-Barré syndrome in northern China. The spectrum of neuropathological changes in clinically defined cases. Brain 1995; 118:577-95.
5. Ho TW, Mishu B, Li CY, Gao CY, Cornblath DR, Griffin JW, Asbury AK, Blaser MJ, McKhann GM. Guillain-Barré syndrome in northern China. Relationship to Campylobacter jejuni infection and anti-glycolipid antibodies. Brain 1995; 118:597-605.
6. Rees JH, Soudain SE, Gregson NA, Hughes RAC. Campylobacter jejuni infection and Guillain-Barré syndrome. N Engl J Med 1995; 333:1374-9.
7. Ogawara K, Kuwabara S, Mori M, Hattori T, Koga M, Yuki N. Axonal Guillain-Barré syndrome: relation to anti-ganglioside antibodies and Campylobacter jejuni infection in Japan. Ann Neurol 2000; 48:624-31.
8. Yuki N, Taki T, Inagaki F, Kasama T, Takahashi M, Saito K, Handa S, Miyatake T. A bacterium lipopolysaccharide that elicits Guillain-Barré syndrome has a GM1 ganglioside-like structure. J Exp Med 1993; 178:1771-5.
9. Aspinall GO, Fujimoto S, McDonald AG, Pang H, Kurjanczyk LA, Penner JL. Lipopolysaccharides from Campylobacter jejuni associated with Guillain-Barré syndrome patients mimic human ganglioside in structure. Infect Immun 1994; 62:2122-5.
10. Guerry P, Szymanski CM, Prendergast MM, Hickey TE, Ewing CP, Pattarini DL, Moran AP. Phase variation of Campylobacter jejuni 81-176 lipooligosaccharide affects ganglioside mimicry and invasiveness in vitro. Infect Immun 2002; 70:787-93.
11. Yuki N, Susuki K, Koga M. Carbohydrate mimicry between human ganglioside GM1 and Campylobacter jejuni lipooligosaccharide causes Guillain-Barré syndrome. Proc Natl Acad Sci USA 2004; 101: 11404-9.
12. Caporale CM, Capasso M, Luciani M, et al Experimental axonal neuropathy induced by immunization with Campylobacter jejuni lipopolysaccharide from a patient with Guillain-Barré syndrome. J Neuroimmunol 2006;174:12-20.
13. Griffin JW, Li CY, Ho TW. Pathology of the motor-sensory axonal Guillain Barré syndrome. Ann Neurol 1996; 39:577-95.
14. Hafer-Macko C, Hsieh ST, Li CY, Ho TW, Sheikh K, Cornblath DR, McKhann GM, Asbury AK, Griffin JW. Acute motor axonal neuropathy: an antibody-mediated attack on axolemma. Ann Neurol 1996; 40: 635-44.
15. Yuki N. Ganglioside mimicry and peripheral nerve disease. Muscle Nerve 2007; 35:691-711.
16. Brigl M, Brenner MB. CD1: antigen presentation and T cell function. Annu Rev Immunol 2004; 22:817-90.
17. Zubler RH. Naive and memory B cells in T-cell-dependent and T-independent responses Springer Semin Immunopathol 2004; 23:405-19.
18. Willison HJ, Kennedy PG. Gangliosides and bacterial toxins in Guillain-Barré syndrome. J Neuroimmunol 1993; 46:105-12.
19. Mitzutamari RK, Kremer LJ, Basile EA, Nores GA. Anti-GM1 ganglioside IgM-antibodies present in human plasma: affinity and biological activity changes in a patient with neuropathy. J Neurosci Res 1998; 51:237-42.
20. Garcia Guijo C, Garcia-Merino A, Rubio G, Guerrero A, Cruz Martinez A, Arpa J. IgG anti-ganglioside antibodies and their subclass distribution in two patients with acute and chronic motor neuropathy. J Neuroimmunol 1992; 37:141-8.
21. Willison HJ, Veitch J. Immunoglobulin subclass distribution and binding characteristics of anti-GQ1b antibodies in Miller Fisher syndrome. J Neuroimmunol 1994; 50:159-65.
22. Yuki N, Ichihashi Y, Taki T. Subclass of IgG antibody to GMl epitope-bearing lipopolysaccharide of Campylobacter jejuni in patients with Guillain-Barré syndrome. J Neuroimmunol 1995; 60:161-4.
23. Hadden RD, Cornblath DR, Hughes RA, Zielasek J, Hartung HP, Toyka KV, Swan AV. Electrophysiological classification of Guillain-Barré syndrome: clinical association and outcome. Ann Neurol 1998; 44:780-8.
24. Caporale CM, Papola F, Fioroni MA, Aureli A, Giovannini A, Notturno F, Adorno D, Caporale V, Uncini A. Susceptibility to Guillain-Barré syndrome is associated to polymorphisms of CD1 genes. J Neuroimmunol 2006; 177:112-8.
25. Willison HJ, Veitch J, Swan AV, et al. Inter-laboratory validation of an ELISA for the determination of serum anti-ganglioside antibodies. Eur J Neurol 1999; 6:71-7.
26. Angelini DF, Borsellino G, Poupot M, Diamantini A, Poupot R, Bernardi G, Poccia F, Fournié JJ, Battistini L. FcgammaRIII discriminates between 2 subsets of Vgamma 9Vdelta2 effector cells with different responses and activation pathways. Blood 2004; 104:1801-7.
27. Ben-Smith A, Goodall JC, Gaston JS, Winer JB. Stimulation of peripheral blood lymphocytes with Campylobacter jejuni generates a gammadelta T cell response in patients with Guillain-Barré syndrome. Clin Exp Immunol 1997; 109:121-6.
28. Van Rhijn I, van den Berg LH, Ang CW, Admiraal J, Logtenberg T. Expansion of human gammadelta T cells after in vitro stimulation with Campylobacter jejuni. Int Immunol 2003; 15:373-82.
29. Van Rhijn I, Logtenberg T, Ang CW, van den Berg LH. Gammadelta T cell non-responsiveness in Campylobacter jejuni-associated Guillain-Barré syndrome patients. Neurology 2003; 61:994-6.
30. Csurhes PA, Sullivan A, Green K, Judith M, Pender MP, McCombe PA. Increased circulating T cell reactivity to GMl ganglioside in patients with Guillain-Barré syndrome. J Clin Neurosci 2005; 12: 409-15.
31. Akira S, Uematsu S, Takeuchi O. Pathogen recognition and innate immunity. Cell 2006; 124: 783-801.
32. Di Rosa F, Santoni A. Bone marrow CD8 T cells are in a different activation state than those in lymphoid periphery. Eur J Immunol 2002; 32:873-80.
33. Parretta E, Cassese G, Barba P, Santoni A, Guardiola J, Di Rosa F. CD8 cell division maintaining cytotoxic memory occurs predominantly in the bone marrow. J Immunol. 2005; 174:7654-64.
34. Shamshiev A, Dondal A, Carenal I, Moril L, Kappos L, De Libero G. Self glycolipid reactive T cells. Eur J Immunol 1999; 29:1667-75.
35. Susuki K, Rasband MN, Tohyama K, Koibuchi K, Okamoto S, Funakoshi K, Hirata K, Baba H, Yuki N. Anti-GM1 antibodies cause complement-mediated disruption of sodium channel clusters in peripheral motor nerve fibers. J Neurosci 2007; 27: 3956-67.
36. Borsellino G, Poccia F, Placido R, et al. Phenotypic and functional properties of gamma delta T cells from patients with Guillain-Barré syndrome. J Neuroimmunol 2000; 102: 199-207.
37. Quigley MF, Gonzalez VD, Granath A, Andersson J, Sandberg JK. CXCR5+ CCR7- CD8 T cells are early effector memory cells that infiltrate tonsil B cell follicles. Eur J Immunol 2007; 37:3352-62.